Endocarditis Clinical Trial
Official title:
Accelerated Treatment of Endocarditis
Existing guidelines recommend a duration of antibiotic treatment of endocarditis of 4-6 weeks one or more types of intravenously administered antibiotics. The long hospitalization increases several risks for the patient, including mental strain and increased loss of function. Furthermore, it poses a significant financial burden on the health systems. Current guidelines fail to use available clinical and paraclinical, data collected from patients (echo, temperature, CRP, leukocytes, procalcitonin etc.) to determine duration of treatment. A strategy including these data in treatment algorithms ensures an individualized treatment, targeting the individual patient's course and response to treatment. Thus, the purpose of this open-label, prospective, non-inferiority, RCT study is to investigate the safety and effectiveness of shortening treatment of endocarditis based on the individual patient's initial treatment response, sampling 475 patients, approx. 125 patients with each type of bacteria (Streptococci; Enterococcus faecalis; Staphylococcus aureus).
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05547607 -
Clinical and Diagnostic Features of Endocarditis
|
||
| Completed |
NCT00750373 -
Early Surgery Versus Conventional Treatment in Infective Endocarditis
|
Phase 4 | |
| Recruiting |
NCT03690076 -
Human Cardiac Mitochondria in Acute Endocarditis and Obesity
|
||
| Terminated |
NCT01734694 -
Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients
|
Phase 4 | |
| Terminated |
NCT00995384 -
Cardiac Computed Tomography (CT) Scan Compared to Transesophageal Echocardiogram (TEE) in Endocarditis
|
N/A | |
| Completed |
NCT04309591 -
Cytosorb Therapy in Cardiac Surgery
|
||
| Recruiting |
NCT05142891 -
Renal Tolerance of Amoxicillin and Cloxacillin Combination
|
||
| Recruiting |
NCT05703022 -
Early Exercise Training in Patients Following Heart Valve Surgery for Infective Endocarditis.
|
N/A | |
| Completed |
NCT01431326 -
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
|
||
| Completed |
NCT03377465 -
Biomarkers, Hemodynamic and Echocardiographic Predictors of Ischemic Strokes and Their Influence on the Course and Prognosis
|
N/A | |
| Recruiting |
NCT03892174 -
Cytokine REmoval in CRitically Ill pAtients Requiring Surgical Therapy for Infective Endocarditis (RECReATE)
|
N/A | |
| Completed |
NCT03695861 -
Contribution of 18F-FDG PET-CT in the Diagnosis and the Detection of Peripheral Emboli of Infectious Endocarditis on Native Valves
|
N/A | |
| Recruiting |
NCT02759978 -
Individualized Diagnosis of Endocarditis and Its Therapy With a Focus on Infected Prosthetic materiAL
|
||
| Completed |
NCT00709358 -
Diagnosis of Septicaemia by Detection of Microbial DNA in Blood in Severe Infections
|
Phase 4 | |
| Terminated |
NCT03148756 -
Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective Endocarditis
|
Phase 2 | |
| Enrolling by invitation |
NCT05156437 -
Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL)
|
Phase 4 | |
| Recruiting |
NCT06107309 -
Suppressive Antibiotic Therapy for Endocarditis
|
||
| Completed |
NCT02251262 -
Diagnostic Accuracy of 18FDG-PET-CT for Pacing or Defibrillation Lead Infection
|
N/A | |
| Recruiting |
NCT03112356 -
The Value of 99mTc-Leukoscan® Scintigraphy in the Diagnosis of Infectious Endocarditis on Surgical Materials
|
Phase 4 | |
| Completed |
NCT01375257 -
Partial Oral Treatment of Endocarditis
|
Phase 4 |